Notice
Recent Posts
Recent Comments
일 | 월 | 화 | 수 | 목 | 금 | 토 |
---|---|---|---|---|---|---|
1 | 2 | 3 | 4 | |||
5 | 6 | 7 | 8 | 9 | 10 | 11 |
12 | 13 | 14 | 15 | 16 | 17 | 18 |
19 | 20 | 21 | 22 | 23 | 24 | 25 |
26 | 27 | 28 | 29 | 30 | 31 |
Tags
- Japan
- M&A
- Confidential Agreement
- CA
- Merger
- Investment
- nda
- taiwan
- Japan Tobacco
- Acquistion
- capital gate
- cgi korea
- China Construction Bank
- LOI
- Malaysia
- Korea M&A
- OTCBB
- buyout
- securities
- Korea
- acquisition
- Letter of intent
- case study
- LOTTE
- PEF
- sk
- hong kong
- China
- private equity
- Bank
Archives
- Today
- Total
Korea M&A Corporation
GlaxoSmithKline and OncoMed Pharmaceuticals form strategic alliance
GlaxoSmithKline (GSK) and OncoMed Pharmaceuticals (OncoMed) today announced a worldwide strategic alliance to discover, develop and market novel antibody therapeutics to target cancer stem cells which are believed to play a key role in the establishment, metastasis and recurrence of cancer. The alliance with GSK will be conducted through its Center of Excellencefor External Drug Discovery (CEEDD..
News/ETC
2007. 12. 15. 09:13